Evidence map›Paper›PMID 39404790›Full record

Trial reportEuropean journal of nuclear medicine and molecular imaging2025

[

Yun Chen, Shan Zheng, Jie Zang, Zezhong Shao, Dongmei Tu, Qun Liu, Xiaoyuan Chen, Weibing Miao, Jingjing Zhang

Registry-linked trialAbstract readClinical Trial, Phase IClinical Trial, Phase IIComparative Study
PubMed Publisher
In one paragraph

Trial report in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05515783 (68Ga-FAP-RGD PET/CT), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05515783 phase1 / phase2unknown statusnot on this map

68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies in Cancer Patients

TypeinterventionalSponsorFirst Affiliated Hospital of Fujian Medical UniversityRan2022 to 2024Enrolled50ConditionsTumorArms68Ga-FAP-RGD
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Diagnostic Value of [Molecular imaging and biology · 2025
    Article
  2. Evaluation ofAmerican journal of nuclear medicine and molecular imaging · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yun Chen *Department of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Shan Zheng *Department of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Jie ZangDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Zezhong ShaoDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Dongmei TuDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Qun LiuDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Xiaoyuan ChenDepartments of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore. chen.shawn@nus.edu.sg.
Weibing MiaoDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China. miaoweibing@126.com.
Jingjing ZhangDepartments of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore. j.zhang@nus.edu.sg.ORCID 0000-0002-6948-1813

Funding

National University of Singapore NUHSRO/2021/097/Startup/13
6 · The paper itself

Abstract

purposeThis head-to-head comparison study aimed to compare the performance of [

methodsTen unexplained hyperthyroglobulinemia (UHTg) patients and 20 patients with definite metastatic lesions of thyroid cancer (DmDTC) were enrolled in the study. All patients underwent both [

resultsIn patients with UHTg, [

conclusionCompared with 2-[ CLINICALTRIALS: gov/ct2/show/NCT05515783.

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyThyroid NeoplasmsAdultAgedFemaleGallium RadioisotopesHumansMaleMiddle AgedNeoplasm MetastasisQuinolinesRadiopharmaceuticals68Ga-FAPIFluorodeoxyglucose F18Gallium RadioisotopesQuinolinesRadiopharmaceuticals2-[18F]FDG[68Ga]Ga-LNC1007HyperthyroglobulinemiaMetastatic differentiated thyroid cancerPET/CT

Identifiers

PMID39404790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.